Amit Govil
Division Director · University of Cincinnati Medical Center Inc.
Credentials: · · · · ·
History
PresentKidney Transplantation · University of Cincinnati Medical Center Inc.
- 2005–2006
University of Cincinnati and transplant nephrology fellowship
2003–2005- 2002–2003
- 1997–2002
- 1994–1997
G.B. Pant Hospital
- 1990–1994
Research
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection
Transplantation · 2008 · 315 citations
American Journal of Transplantation · 2009 · 175 citations
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection
Case report · Transplantation · 2010 · 154 citations
- EH
18 papers
- AC
17 papers · 3 as a resident
16 papers
14 papers
- MC
10 papers
10 papers
9 papers
6 papers
Clinical trials
- 2019–2022
Veloxis de Novo Kidney Transplant ECSWD
Sub-investigator · Unknown · Phase 4
Simon Tremblay, PharmD, PhD
- 2015–2020